Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells

Molecular Pharmaceutics

Volumn 4, Issue 1, 2007, Pages 47-57

  Solbrig, C M ^a   Saucier Sawyer, J K ^a   Cody, V ^b   Saltzman, W M ^a,c,d   Hanlon, D J ^b  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Antigen delivery; B16 melanoma; Cell lysates; Nanoparticle; PLGA

Indexed keywords

GLYCOPROTEIN GP 100; NANOPARTICLE; OVALBUMIN; POLYGLACTIN; POLYMER; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; IMMUNOTHERAPY; MELANOMA B16; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR CELL; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; IMMUNOTHERAPY; LACTIC ACID; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; NANOPARTICLES; NEOPLASMS; OVALBUMIN; POLYGLYCOLIC ACID; POLYMERS;

EID: 33847175513     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060107e     Document Type: Article

References (25)

1. Mocellin, S.; Mandruzzato, S.; Bronte, V.; Lise, M.; Donato, N. Part I: Vaccines for solid tumours. Lancet Oncol. 2004, 5, 681-689.
2. Gong, J. Immunotherapy of cancer based on DC-tumor fusion vaccine. Curr. Immunol. Rev. 2006, 2 (3), 291-304.
3. Shen, H.; Ackerman, V.; Cody, V.; Giodini, A.; Hinson, E. R.; Cresswell, P.; Edelson, R. L.; Saltzman, W. M.; Hanlon, D. J. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 2006, 117, 78-88.
4. Wong, H. M.; Wang, J. J.; Wang, C. H. In vitro sustained release of human immunoglobulin G from biodegradable microspheres. Ind. Eng. Chem. Res. 2001, 40, 933-948.
5. Jiang, G.; Woo, B. H.; Kang, F.; Singh, J.; DeLuca, P. P. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsultaed poly(D,L-lactide-co-glycolide) microspheres. J. Controlled Release 2002, 79, 137-145.
6. Sohier, J.; Vlugt, T. J. H.; Cabrol, N.; Van Blitterswijk, C.; de Groot, K.; Bezemer, K. M. Dual release of proteins from porous polymeric scaffolds. J. Controlled Release 2006, 111, 95-106.
7. Park, T. G.; Lu, W.; Crotts, G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Controlled Release 1995, 33, 211-222.
8. Murillo, M.; Grillo, M. J.; Rene, J.; Marin, C. M.; Barberan, M.; Goni, M. M.; Blasco, J. M.; Irache, J. M.; Gamazo, C. A Brucella ovis antigenic complex bearing (poly-ε-caprolactone) microparticles confer protection against experimental brucellosis in mice. Vaccine 2001, 19, 4099-4106.
9. Ren, J. M.; Zou, Q. M.; Wang, F. K.; He, Q.; Chen, W.; Zen, W. K. PELA microspheres loaded H. pylori lysates and their mucosal immune response. World J. Gastroenterol. 2002, 8 (6), 1098-1102.
10. Santos-Sanchez, A. Formulation, in vitro characterization and in vivo evaluation of a biodegradable campthothecin sustained release delivery system for intratumoral treatments of breast cancer. Ph.D. Thesis. Cornell University, Ithaca, NY, 2004.
11. Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 1991, 8 (6), 713-720.
12. Overwijk, W. W.; Theoret, M. R.; Finkelstein, S. E.; Surman, D. R.; DeJong, L. A.; Vyth-Dreese, F. A.; Dellemijn, T. A.; Antony, P. A.; Spiess, P. J.; Palmer, D. C.; Heimann, D. M.; Klebanoff, C. A.; Yu, Z.; Hwang, L. N.; Feigenbaum, L.; Kruisbeek, A. M.; Rosenberg, S. A.; Restifo, N. P. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 2003, 198 (4), 569-580.
13. Dranoff, G.; Jaffee, E.; Lazenby, A.; Golumbek, P.; Levitsky, H.; Brose, K.; Jackson, V.; Hamada, H.; Pardoll, D.; Mulligan, R. C. Vaccination with irradiated tumor-cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity. Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (8), 3539-3543.
14. Mathiowitz, E.; Saltzman, W. M.; Domb, A.; Dor, P.; Langer, R. Polyanhydride microspheres as drug carriers. 2. Microencapsulation by solvent removal. J. Appl. Polym. Sci. 1988, 35, 755-774.
15. Spenlehauer, G.; Spenlehauer-Bonthonneau, F.; Thies, C. Biodegradable microparticles for delivery of polypeptides and proteins. Prog. Clin. Biol. Res. 1989, 292, 283-291.
16. Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L.; Langer, R. Contolled delivery systems for protiens based on poly(lactic glycolic acid) microspheres. Pharm. Res. 1991, 8, 713-720.
17. Krewson, C. E.; Dause, R. B.; Mak, M. W.; Saltzman, W. M. Stabilization of nerve growth factor in controlled release polymers and in tissue. J. Biomater. Sci. 1996, 8, 103-117.
18. Yang, Y.-Y.; Chung, T. S.; Ng, N. P. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001, 22, 2331-2341.
19. Tamber, H.; Johansen, P.; Merkle, H. P.; Gander, B. Formulation aspects of biodegradable polymeric microspherees for antigen delivery. Adv. Drug Delivery Rev. 2005, 57, 357-376.
20. Cao, X.; Shoichet, M. S. Delivering neuroactive molecules from biodegradable microsphteres for application in central nervous system disorders. Biomaterials 1999, 20, 329-339.
21. Murillo, M.; Goni, M. M.; Irache, J. M.; Arangoa, M. A.; Blasco, J. M.; Gamazo, C. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing brucella ovis antigens. J. Controlled Release 2002, 85, 237-246.
22. Benoit, M. A.; Baras, B.; Gillard, J. Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery. Int. J. Pharm. 1999, 184, 73-84.
23. Youan, B.-B. C. Influence of protein content on the physicochemistry of poly(ε-caprolactone) microparticles. J. Appl. Polym. Sci. 2006, 101 (2), 1042-1050.
24. Alonso, M. J.; Cohen, S.; Park, T. G.; Gupta, R. K.; Siber, G. R.; Langer, R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 1993, 10 (7), 945-953.
25. Engelhard, V. H.; Bullock, T. N.; Colella, T. A.; Sheasley, S. L.; Mullins, D. W. Antigens derived from melanocyte differentiation proteins: Self-tolerance, autoimmunity, and use for cancer immunotherapy, Immunol. Rev. 2002, 188, 136-146.